Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction

Frontiers in Physiology

Volumn 5 JUL, Issue , 2014, Pages

  Czikora, Istvan ^a   Sridhar, Supriya ^a   Gorshkov, Boris ^a   Alieva, Irina B ^a,b   Kasa, Anita ^a   Gonzales, Joyce ^c   Potapenko, Olena ^a   Umapathy, Nagavedi S ^a   Pillich, Helena ^d   Rick, Ferenc G ^e,f   Block, Norman L ^e,g   Verin, Alexander D ^a   Chakraborty, Trinad ^e   Matthay, Michael A ^h   Schally, Andrew V ^e,g   Lucas, Rudolf ^a,c  

^a AUGUSTA UNIVERSITY   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Capillary leak; Growth hormone releasing hormone; Lipopolysaccharide; Pneumolysin; Protein kinase A; Protein kinase C

Indexed keywords

CADHERIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; JI 34; LIPOPOLYSACCHARIDE; PNEUMOLYSIN; PROTEIN KINASE C; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BACTERIAL TOXIN; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; PROTEIN KINASE C ALPHA; TUMOR NECROSIS FACTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ENDOTHELIUM; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PULMONARY BARRIER DYSFUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; DRUG ACTIVITY; DRUG EFFICACY; IMMUNOREACTIVITY; LUNG DISEASE; LUNG LAVAGE; POLYMERIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 84904287601     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00259     Document Type: Article

References (39)

1. Aggarwal, S., Gross, C. M., Kumar, S., Dimitropoulou, C., Sharma, S., Gorshkov, B. A., et al. (2014). Dimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury. Am. J. Respir. Cell Mol. Biol. 50, 614-625. doi: 10.1165/rcmb.2013-0193OC.
2. Anderson, R., Steel, H. C., Cockeran, R., Von Gottberg, A., de Gouveia, L., Klugman, K. P., et al. (2007). Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J. Antimicrob. Chemother. 60, 1155-1158. doi: 10.1093/jac/dkm338.
3. Beutler, B., and Moresco, E. M. (2008). The forward genetic dissection of afferent innate immunity. Curr. Topics Microbiol. Immunol. 321, 3-26.
4. Bogatcheva, N. V., Zemskova, M. A., Kovalenkov, Y., Poirier, C., and Verin, A. D. (2009). Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. J. Cell. Physiol. 221, 750-759. doi: 10.1002/jcp.21913.
5. Cai, R., Schally, A. V., Cui, T., Szalontay, L., Halmos, G., Sha, W., et al. (2014). Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities. Peptides 52, 104-112. doi: 10.1016/j.peptides.2013.12.010.
6. Colice, G. L., Matthay, M. A., Bass, E., and Matthay, R. A. (1984). Neurogenic pulmonary edema. Am. Rev. Respir. Dis. 130, 941-948.
7. Csortos, C., Czikora, I., Bogatcheva, N. V., Adyshev, D. M., Poirier, C., Olah, G., et al. (2008). TIMAP is a positive regulator of pulmonary endothelial barrier function. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L440-L450. doi: 10.1152/ajplung.00325.2007.
8. Dejana, E., Orsenigo, F., and Lampugnani, M. G. (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 121(Pt 13), 2115-2122. doi: 10.1242/jcs.017897.
9. Dudek, S. M., and Garcia, J. G. (2001). Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91, 1487-1500.
10. Evans, G. M., and Gaisford, W. F. (1938). Treatment of pneumonia with 2-(p-Aminobenzenesulphonamido) pyridine. Lancet 2, 14-18. doi: 10.1016/S0140-6736(00)87996-9.
11. Fukuhara, S., Sakurai, A., Sano, H., Yamagishi, A., Somekawa, S., Takakura, N., et al. (2005). Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 25, 136-146. doi: 10.1128/MCB.25.1.136-146.2005.
12. Gonzales, J. N., Gorshkov, B., Varn, M. N., Zemskova, M. A., Zemskov, E. A., Sridhar, S., et al. (2014). Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 306, L497-L507. doi: 10.1152/ajplung.00086.2013.
13. Herwig, M. C., Tsokos, M., Hermanns, M. I., Kirkpatrick, C. J., and Müller, A. M. (2013). Vascular endothelial cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures. Pathobiology 80, 245-251. doi: 10.1159/000347062.
14. Izdebski, J., Pinski, J., Horvath, J. E., Halmos, G., Groot, K., and Schally, A. V. (1995). Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc. Natl. Acad. Sci. U.S.A. 92, 4872-4876. doi: 10.1073/pnas.92.11.4872.
15. Kanashiro-Takeuchi, R. M., Tziomalos, K., Takeuchi, L. M., Treuer, A. V., Lamirault, G., Dulce, R., et al. (2010). Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 107, 2604-2609. doi: 10.1073/pnas.0914138107.
16. Kiaris, H., Chatzistamou, I., Papavassiliou, A. G., and Schally, A. V. (2011). Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol. Metab. 22, 311-317. doi: 10.1016/j.tem.2011.03.006.
17. Lania, A., Filopanti, M., Corbetta, S., Losa, M., Ballaré, E., Beck-Peccoz, P., et al. (2003). Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells. J. Clin. Endocrinol. Metab. 88, 1692-1696. doi: 10.1210/jc.2002-021207.
18. Lawrence, D. W., Comerford, K. M., and Colgan, S. P. (2002). Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am. J. Physiol. Cell Physiol. 282, C1235-C1245. 10.1152/ajpcell.00288.2001.
19. Lucas, R., Czikora, I., Sridhar, S., Zemskov, E. A., Oseghale, A., Circo, S., et al. (2013). Arginase 1: an unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury. Front. Immunol. 4:228. doi: 10.3389/fimmu.2013.00228.
20. Lucas, R., Sridhar, S., Rick, F. C., Gorshkov, B., Umapathy, N. S., Yang, G., et al. (2012a). Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proc. Natl. Acad. Sci. U.S.A. 109, 2084-2089. doi: 10.1073/pnas.1121075109.
21. Lucas, R., Verin, A. D., Black, S. M., and Catravas, J. D. (2009). Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem. Pharmacol. 77, 1763-1772. doi: 10.1016/j.bcp.2009.01.014.
22. Lucas, R., Yang, G., Gorshkov, B. A., Zemskov, E. A., Sridhar, S., Umapathy, N. S., et al. (2012b). Protein kinase C-alpha and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. Am. J. Respir. Cell Mol. Biol. 47, 445-453. doi: 10.1165/rcmb.2011-0332OC.
23. Ludwig, B., Rotem, A., Schmid, J., Weir, G. C., Colton, C. K., Brendel, M. D., et al. (2012). Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc. Natl. Acad. Sci. U.S.A. 109, 5022-5027. doi: 10.1073/pnas.1201868109.
24. Maus, U. A., Srivastava, M., Paton, J. C., Mack, M., Everhart, M. B., Blackwell, T. S., et al. (2004). Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J. Immunol. 173, 1307-1312. doi: 10.4049/jimmunol.173.2.1307.
25. Mayo, K. E., Godfrey, P. A., Suhr, S. T., Kulik, D. J., and Rahal, J. O. (1995). Growth hormone-releasing hormone: synthesis and signaling. Recent Prog. Horm. Res. 50, 35-73.
26. Moretti, C., Mencacci, C., Frajese, G. V., Cerilli, M., and Frajese, G. (2002). Growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide in the reproductive system. Trends Endocrinol. Metab. 13, 428-435. doi: 10.1016/S1043-2760(02)00632-X.
27. Petrache, I., Birukova, A., Ramirez, S. I., Garcia, J. G., and Verin, A. D. (2003). The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am. J. Resp. Cell. Mol. Biol. 28, 574-581. doi: 10.1165/rcmb.2002-0075OC.
28. Qiao, J., Holian, O., Lee, B. S., Huang, F., Zhang, J., and Lum, H. (2008). Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA. Am. J. Physiol. Cell Physiol. 295, C1161-C1168. doi: 10.1152/ajpcell.00139.2008.
29. Rafikov, R., Dimitropoulou, C., Aggarwal, S., Kangath, A., Gross, C., Pardo, D., et al. (2014). Lipopolysaccharide-induced lung injury involves the nitration-mediated activation of RhoA. J. Biol. Chem. 289, 4710-4722. doi: 10.1074/jbc.M114.547596.
30. Rekasi, Z., Czompoly, T., Schally, A. V., and Halmos, G. (2000). Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc. Natl. Acad. Sci. U.S.A. 97, 10561-10566. doi: 10.1073/pnas.180313297.
31. Rubins, J. B., Charboneau, D., Fasching, C., Berry, A. M., Paton, J. C., Alexander, J. E., et al. (1996). Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 153, 1339-1346. doi: 10.1164/ajrccm.153.4.8616564.
32. Rudan, I., Boschi-Pinto, C., Biloglav, Z., Mulholland, K., and Campbell, H. (2008). Epidemiology and etiology of childhood pneumonia. Bull. World Health Organ. 86, 408-416. doi: 10.2471/BLT.07.048769.
33. Schlegel, N., Baumer, Y., Drenckhahn, D., and Waschke, J. (2009). Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro. Crit. Care Med. 37, 1735-1743. doi: 10.1097/CCM.0b013e31819deb6a.
34. Sherwood, N. M., Krueckl, S. L., and McRory, J. E. (2000). The origin and function of the pituitary adenylate cyclase activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 21, 619-670. doi: 10.1210/edrv.21.6.0414.
35. Umapathy, N. S., Gonzales, J., Fulzele, S., Kim, K. M., Lucas, R., and Verin, A. D. (2012). β-Nicotinamide adenine dinucleotide attenuates lipopolysaccharide-induced inflammatory effects in a murine model of acute lung injury. Exp. Lung Res. 38, 223-232. doi: 10.3109/01902148.2012.673049.
36. Umapathy, N. S., Zemskov, E. A., Gonzales, J., Gorshkov, B. A., Sridhar, S., Chakraborty, T., et al. (2010). Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. J. Cell. Physiol. 223, 215-223. doi: 10.1002/jcp.22029.
37. Waterer, G. W., Rello, J., and Wunderink, R. G. (2011). Management of community-acquired pneumonia in adults. Am. J. Respir. Crit. Care Med. 183, 157-164. doi: 10.1164/rccm.201002-0272CI.
38. Witzenrath, M., Gutbier, B., Hocke, A. C., Schmeck, B., Hippenstiel, S., Berger, K., et al. (2006). Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit. Care Med. 34, 1947-1954. doi: 10.1097/01.CCM.0000220496.48295.A9.
39. Zhao, Y., Zhao, J., Mialki, R. K., Wei, J., Spannhake, E. W., Salgia, R., et al. (2013). Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L56-L63. doi: 10.1152/ajplung.00417.2012.